Skip to content
ClinCalc Pro
Menu
geriatrics

Clinical Frailty Scale (CFS)

9-level clinical tool for assessing frailty in older adults. Based on clinical judgement integrating mobility, energy, physical activity, and function. Score 1 = very fit; score 9 = terminally ill. Widely used for clinical decision-making.

Score interpretation

Not Frail (CFS 1–3) 1–3

Very fit, fit or managing well (CFS version 2.0).

→ Standard care; preventive health advice; healthy ageing promotion; pre-habilitation if major surgery planned.

Living with Very Mild Frailty (CFS 4) 4

Not dependent on others for daily help, but symptoms often limit activities (previously 'vulnerable').

→ Identify and address modifiable factors (exercise, nutrition, social engagement); optimise long-term conditions; falls and functional review.

Mild to Moderate Frailty (CFS 5–6) 5–6

CFS 5: needs help with higher-order IADLs; CFS 6: needs help with all outside activities and keeping house.

→ Comprehensive geriatric assessment (CGA); physiotherapy, OT; medication review; falls assessment; nutritional review; social care input; advance care planning discussion; careful consideration of major interventional treatments.

Severe to Very Severe Frailty (CFS 7–8) 7–8

Completely dependent for personal care; at CFS 8 approaching end of life and typically could not recover even from a minor illness.

→ Comprehensive geriatric assessment; MDT with palliative care involvement; goals of care discussion; advance care planning and DNACPR consideration; senior clinical decision-making involvement.

Terminally Ill (CFS 9) 9

Approaching the end of life: life expectancy < 6 months, not otherwise living with severe frailty.

→ Palliative and end-of-life care; symptom management; advance care planning; family meeting.

Interpretation bands for the Clinical Frailty Scale. Apply clinical judgement and local guidance.

References

Related

Curated clinical cross-links plus same-class fallbacks.

Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.